MIKAJAKI Announces CE Marking for EyeLib™

Thank you to all those who participated in our feasibility study, it was a resounding success. If you’d like to receive information about future studies, please get in touch with us.

Company News


Société Française d’Ophtalmologie in Paris was a huge success

MIKAJAKI attended Société Française d’Ophtalmologie in Paris this past May 7-9 and the event was an overwhelming success.

MIKAJAKI teams up with SEGULA Technologies

MIKAJAKI has teamed up with engineering group SEGULA Technologies to develop and deploy the first fully operational EyeLib™ this summer. View the full press release.

World news

Read the latest news about MIKAJAKI from countries around the globe.

MIKAJAKI Receives ISO 13485:2016 Certification

MIKAJAKI is excited to announce a new milestone with certification of its quality management system (QMS) under ISO:13485:2016. Read the full press release.

MIKAJAKI is featured by CRST Europe

MIKAJAKi has been featured in an article published by the leading ophthalmology magazine CRST Europe about emerging AI and Big Data Applications in Ophthalmology. Read the article.

Come and join us at the Virtual Venture Day on 24.03.2021

Come and join us at the Virtual Venture Day on 24.03.2021. You can virtually meet us at the startup booths and at the 1:1 meeting elevator

MIKAJAKI Announces CE Marking for EyeLib™

After achieving this important milestone, MIKAJAKI will be proceeding with a limited commercial product roll out of the EyeLib™.  Read the Press Release.

Come visit with us virtually at the SFO 1er E-congrès

You’re invited to visit with MIKAJAKI at our upcoming virtual on on the 5th and 6th of September. Read more about the event and sign up online. We’re looking forward to seeing you there.

The future of eye healthcare is changing

The future of ophthalmology has arrived…right here in Geneva. Listen to an exciting radio interview with Benoît Rouchaleau of Radio LAC as he discusses how MIKAJAKI is changing the future of eye healthcare.

BlueOcean Ventures invests in MIKAJAKI

The water is clear and blue with Blue Ocean’s investment in MIKAJAKI. We’re excited to receive Blue Ocean’s support as we create the world’s first ophthalmic diagnostic robotic platform.

Platinn features the MIKAJAKI founders

L’avenir du diagnostic ophtalmologique se joue sous nos yeux

Financial magazine Bilan ranks MIKAJAKI in top 50 Swiss startups

We are happy to inform you that MIKAJAKI was listed in the Swiss economic magazine Bilan as one of the top “50 Swiss Startups in which to Invest in 2020”.

The MIKAJAKI team is growing!

We’re excited to announce that our team is growing! We’re hiring in a number of areas. Read on to learn more.

MIKAJAKI is part of Geneva Smart City

We’re excited to be part of Geneva Smart City, a community of tech companies based in Geneva.

Swiss Innovator Innosuisse selects MIKAJAKI

We are very proud to announce that we were selected for stage B of Innosuisse the Swiss Innovation Agency.

MIKAJAKI joins the Fongit Innovation Incubator

Fongit, the leading startup incubator in Switzerland, has accepted MIKAJAKI into it’s incubator program. Learn more about Fongit.